Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Seawater eyedrops are a natural therapeutic intervention being investigated by the American Society of Thermalism and Climatology for the treatment of primary open-angle glaucoma and ocular hypertension. The treatment involves the daily ophthalmic administration of seawater, hypothesized to lower intraocular pressure (IOP) and prevent the progression of glaucoma through the action of trace minerals and osmotic properties. In clinical studies, it has been evaluated both as a monotherapy and in combination with Pulsed Electromagnetic Field Therapy (PEMF), a reparative technique intended to increase blood flow to the eye. This intervention is part of the study of natural therapeutic factors, including seawater and climate-based treatments, rather than a traditional pharmaceutical drug.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on seawater eyedrops.